Cutler Group’s Medifast MED Stock Holding History

Cutler Group’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-8,000	Closed	-$86K	–	4404
2019 Q4	$86K	Buy	8,000 +5,600	+233%	+$542K	0.01%	1283
2019 Q3	$19K	Buy	+2,400	New	+$258K	﹤0.01%	2215
2019 Q2	–	Sell	-1,900	Closed	-$1K	–	4580
2019 Q1	$1K	Buy	+1,900	New	+$241K	﹤0.01%	3722

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cutler Group's MED Position: Q4 2023 in Review

Cutler Group sold out of Medifast (MED) in Q4 2023, closing a stake of 4,000 shares — an estimated $299K sold.

Cutler Group first reported a position in MED in Q1 2016 and held it in 13 quarters. The position peaked at $1.02M in Q4 2019. 216 funds tracked by Wall St. Rank hold MED as of Q4 2023.

Cutler Group reported no remaining Medifast position as of Q4 2023 after selling out during the quarter.
Cutler Group sold 4,000 Medifast shares in Q4 2023, an estimated $299K.
Cutler Group first reported a position in Medifast in Q1 2016 and held it in 13 quarters.
Cutler Group's Medifast position peaked at $1.02M in Q4 2019.
216 funds tracked by Wall St. Rank held Medifast as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.